vs

Side-by-side financial comparison of Crane NXT, Co. (CXT) and Sabra Health Care REIT, Inc. (SBRA). Click either name above to swap in a different company.

Crane NXT, Co. is the larger business by last-quarter revenue ($387.7M vs $221.8M, roughly 1.7× Sabra Health Care REIT, Inc.). Sabra Health Care REIT, Inc. runs the higher net margin — 18.4% vs 1.7%, a 16.8% gap on every dollar of revenue. On growth, Sabra Health Care REIT, Inc. posted the faster year-over-year revenue change (20.8% vs 17.4%). Over the past eight quarters, Sabra Health Care REIT, Inc.'s revenue compounded faster (12.2% CAGR vs 2.3%).

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

Sabra Health Care REIT, Inc. is a specialized real estate investment trust that owns, manages, and invests in a diverse portfolio of healthcare real estate assets. Its core holdings include senior housing facilities, skilled nursing centers, specialty hospital properties, and medical office buildings across the United States, serving key segments of the growing senior care and healthcare delivery markets.

CXT vs SBRA — Head-to-Head

Bigger by revenue
CXT
CXT
1.7× larger
CXT
$387.7M
$221.8M
SBRA
Growing faster (revenue YoY)
SBRA
SBRA
+3.4% gap
SBRA
20.8%
17.4%
CXT
Higher net margin
SBRA
SBRA
16.8% more per $
SBRA
18.4%
1.7%
CXT
Faster 2-yr revenue CAGR
SBRA
SBRA
Annualised
SBRA
12.2%
2.3%
CXT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CXT
CXT
SBRA
SBRA
Revenue
$387.7M
$221.8M
Net Profit
$6.4M
$40.8M
Gross Margin
40.2%
Operating Margin
Net Margin
1.7%
18.4%
Revenue YoY
17.4%
20.8%
Net Profit YoY
-70.5%
1.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXT
CXT
SBRA
SBRA
Q1 26
$387.7M
$221.8M
Q4 25
$476.9M
$211.9M
Q3 25
$445.1M
$190.0M
Q2 25
$404.4M
$189.2M
Q1 25
$330.3M
$183.5M
Q4 24
$399.1M
$182.3M
Q3 24
$403.5M
$178.0M
Q2 24
$370.6M
$176.1M
Net Profit
CXT
CXT
SBRA
SBRA
Q1 26
$6.4M
$40.8M
Q4 25
$47.5M
$27.2M
Q3 25
$50.5M
$22.5M
Q2 25
$24.9M
$65.5M
Q1 25
$21.7M
$40.3M
Q4 24
$46.7M
Q3 24
$47.1M
$29.8M
Q2 24
$41.6M
$24.0M
Gross Margin
CXT
CXT
SBRA
SBRA
Q1 26
40.2%
Q4 25
42.4%
Q3 25
43.3%
Q2 25
41.7%
Q1 25
42.4%
Q4 24
45.2%
Q3 24
42.5%
Q2 24
43.4%
Operating Margin
CXT
CXT
SBRA
SBRA
Q1 26
Q4 25
16.7%
12.3%
Q3 25
18.4%
11.4%
Q2 25
11.8%
34.5%
Q1 25
11.3%
22.1%
Q4 24
17.7%
25.9%
Q3 24
18.6%
16.5%
Q2 24
18.2%
13.8%
Net Margin
CXT
CXT
SBRA
SBRA
Q1 26
1.7%
18.4%
Q4 25
10.0%
12.8%
Q3 25
11.3%
11.9%
Q2 25
6.2%
34.7%
Q1 25
6.6%
22.0%
Q4 24
25.6%
Q3 24
11.7%
16.7%
Q2 24
11.2%
13.6%
EPS (diluted)
CXT
CXT
SBRA
SBRA
Q1 26
Q4 25
$0.82
$0.11
Q3 25
$0.87
$0.09
Q2 25
$0.43
$0.27
Q1 25
$0.38
$0.17
Q4 24
$1.00
$0.20
Q3 24
$0.81
$0.13
Q2 24
$0.72
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXT
CXT
SBRA
SBRA
Cash + ST InvestmentsLiquidity on hand
$228.3M
$116.5M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.2B
$2.8B
Total Assets
$3.6B
$5.6B
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXT
CXT
SBRA
SBRA
Q1 26
$228.3M
$116.5M
Q4 25
$233.8M
$71.5M
Q3 25
$182.4M
$200.6M
Q2 25
$152.5M
$95.2M
Q1 25
$173.8M
$22.7M
Q4 24
$165.8M
$60.5M
Q3 24
$165.1M
$63.0M
Q2 24
$175.5M
$36.4M
Total Debt
CXT
CXT
SBRA
SBRA
Q1 26
$1.5B
Q4 25
$1.0B
$2.5B
Q3 25
$834.3M
$2.6B
Q2 25
$861.8M
$2.5B
Q1 25
$541.1M
$2.4B
Q4 24
$540.6M
$2.4B
Q3 24
$638.2M
$2.5B
Q2 24
$638.9M
$2.4B
Stockholders' Equity
CXT
CXT
SBRA
SBRA
Q1 26
$1.2B
$2.8B
Q4 25
$1.3B
$2.8B
Q3 25
$1.2B
$2.8B
Q2 25
$1.2B
$2.7B
Q1 25
$1.1B
$2.7B
Q4 24
$1.1B
$2.7B
Q3 24
$1.1B
$2.7B
Q2 24
$989.8M
$2.8B
Total Assets
CXT
CXT
SBRA
SBRA
Q1 26
$3.6B
$5.6B
Q4 25
$3.1B
$5.5B
Q3 25
$2.9B
$5.6B
Q2 25
$2.9B
$5.3B
Q1 25
$2.4B
$5.2B
Q4 24
$2.4B
$5.3B
Q3 24
$2.4B
$5.4B
Q2 24
$2.4B
$5.4B
Debt / Equity
CXT
CXT
SBRA
SBRA
Q1 26
1.22×
Q4 25
0.80×
0.90×
Q3 25
0.69×
0.92×
Q2 25
0.73×
0.91×
Q1 25
0.49×
0.89×
Q4 24
0.51×
0.88×
Q3 24
0.60×
0.90×
Q2 24
0.65×
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXT
CXT
SBRA
SBRA
Operating Cash FlowLast quarter
$98.4M
Free Cash FlowOCF − Capex
$-24.1M
FCF MarginFCF / Revenue
-6.2%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
2.41×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXT
CXT
SBRA
SBRA
Q1 26
$98.4M
Q4 25
$105.8M
$348.6M
Q3 25
$92.0M
$100.0M
Q2 25
$62.8M
$81.0M
Q1 25
$-19.1M
$80.3M
Q4 24
$81.1M
$310.5M
Q3 24
$66.7M
$97.7M
Q2 24
$56.8M
$80.1M
Free Cash Flow
CXT
CXT
SBRA
SBRA
Q1 26
$-24.1M
Q4 25
Q3 25
$78.7M
Q2 25
$55.8M
Q1 25
$-32.2M
Q4 24
Q3 24
$53.5M
Q2 24
$47.9M
FCF Margin
CXT
CXT
SBRA
SBRA
Q1 26
-6.2%
Q4 25
Q3 25
17.7%
Q2 25
13.8%
Q1 25
-9.7%
Q4 24
Q3 24
13.3%
Q2 24
12.9%
Capex Intensity
CXT
CXT
SBRA
SBRA
Q1 26
2.6%
Q4 25
Q3 25
3.0%
Q2 25
1.7%
Q1 25
4.0%
Q4 24
Q3 24
3.3%
Q2 24
2.4%
Cash Conversion
CXT
CXT
SBRA
SBRA
Q1 26
2.41×
Q4 25
2.23×
12.80×
Q3 25
1.82×
4.44×
Q2 25
2.52×
1.24×
Q1 25
-0.88×
1.99×
Q4 24
6.65×
Q3 24
1.42×
3.28×
Q2 24
1.37×
3.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXT
CXT

Detection and Traceability Technologies$194.9M50%
Security and Authentication Technologies$192.8M50%

SBRA
SBRA

Resident fees and services$116.7M53%
Rental and related revenues (1)$95.0M43%
Other$10.0M5%

Related Comparisons